Little Green Pharma Ltd (ASX:LGP)

Little Green Pharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Jun 30, 2021
Market Capitalization	29	38	42	54	117	205
Market Cap Growth	-15.83%	-9.75%	-21.65%	-53.97%	-43.09%	337.84%
Enterprise Value	32	38	42	60	104	202
Last Close Price	0.10	0.13	0.14	0.18	0.48	0.88
PE Ratio	4.98	11.41	-	-	-	9.21
PS Ratio	0.76	1.03	1.55	2.70	8.30	29.23
PB Ratio	0.34	0.45	0.54	0.65	1.54	2.24
P/TBV Ratio	0.35	0.47	0.57	0.66	1.56	2.26
P/OCF Ratio	-	-	627.06	-	-	-
EV/Sales Ratio	0.83	1.03	1.53	3.02	7.38	28.82
Debt / Equity Ratio	0.06	0.06	0.07	0.14	0.21	0.14
Net Debt / Equity Ratio	0.03	0.03	0.00	-0.01	-0.06	-0.30
Net Debt / EBITDA Ratio	0.99	-8.16	-0.04	0.12	0.20	78.28
Net Debt / FCF Ratio	-1.37	-1.99	-0.26	0.06	0.13	4.54
Asset Turnover	0.43	0.40	0.29	0.20	-	0.11
Inventory Turnover	0.72	0.84	0.54	0.65	-	0.30
Quick Ratio	0.73	0.73	1.30	1.79	1.55	2.77
Current Ratio	3.19	2.60	3.31	2.82	2.14	3.25
Return on Equity (ROE)	7.38%	4.10%	-10.22%	-10.85%	-	42.80%
Return on Assets (ROA)	-0.33%	-2.42%	-5.04%	-4.61%	-	-0.83%
Return on Capital Employed (ROCE)	-0.50%	-4.00%	-9.30%	-8.20%	-28.20%	-0.90%
Earnings Yield	19.94%	8.77%	-19.40%	-17.17%	-20.93%	10.85%
FCF Yield	-6.49%	-3.04%	-1.54%	-16.33%	-28.38%	-2.96%
Buyback Yield / Dilution	-0.95%	-0.93%	-19.91%	-5.90%	-42.33%	-29.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.